Epidemiological characteristics of fatal Candida krusei fungemia in immunocompromised febrile neutropenic children.
Agirbasli
H
H
Otlu
B
B
Bilgen
H
H
Durmaz
R
R
Gedikoglu
G
G
D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000401:mortality*; D002648:Child; D002675:Child, Preschool; D025141:Drug Resistance, Fungal; D005260:Female; D005334:Fever; D016469:Fungemia / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000401:mortality*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009503:Neutropenia / Q000150:complications*
D000935:Antifungal Agents; D000666:Amphotericin B